Long-term incidence of Parkinson’s disease in rural areas of Finland
Objective: To investigate possible long-term changes in the incidence of Parkinson's disease (PD) in rural regions. Background: Living in rural areas has long been suspected…Characteristics of patients initiating droxidopa for the treatment of neurogenic orthostatic hypotension (nOH)
Objective: To understand the characteristics of patients initiating droxidopa therapy for the treatment of neurogenic orthostatic hypotension (nOH). Background: nOH is defined as a fall…Movement disorders (Parkinson’s disease) in Uzbekistan: Epidemiologic, clinical and therapeutic aspects
Objective: The aim was to determine the epidemiologic, clinical and therapeutic aspects of patients treated for PD. Methods: This was a prospective and cross-sectional study…Impact of neurogenic orthostatic hypotension on healthcare utilization and costs associated with falls in Parkinson’s disease
Objective: To compare demographic and clinical characteristics, rates, and costs of medically attended falls among patients with Parkinson's disease (PD) and probable PD and neurogenic…Ethnic differences in rates of Parkinson’s in New Zealand: A nation-wide prevalence and incidence study
Objective: To estimate the prevalence and incidence of Parkinson's in New Zealand and to investigate if these measures differ between the major ethnic groups represented…Work-related stress and risk for Parkinson’s disease
Objective: To explore the association between work-related stress (job control and job demands) and the risk for Parkinson's disease (PD). Background: Chronic stress is associated…The role of diabetes mellitus and hyperglycemia in early de novo Parkinson’s disease patients
Objective: To investigate the impact of diabetes mellitus (DM) and hyperglycemia in early de novo (untreated) Parkinson's disease (PD) patients. Background: Patients affected by DM…Rotenone and Parkinson’s disease (PD): Effect modification by membrane transporter variants
Objective: Determine whether variants in the xenobiotic efflux membrane transporter p-glycoprotein gene (ABCB1, p-gp, MDR1) modify the association of rotenone and PD. Background: Use of…Association of UV radiation with Parkinson’s disease incidence: A nationwide French ecologic study
Objective: Using ultraviolet B (UV-B) as a surrogate for vitamin D levels, we conducted a nationwide ecologic study in France in order to examine the…Genetic risk of Parkinson’s disease in the general population
Objective: We investigated whether a genetic risk score for Parkinson's disease (PD) is associated with the risk of incident PD, and whether the risk score…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.